Saturday 17 October 2026
Export IVPR’s income statement to Excel — free account
Inspire Veterinary Partners, Inc.
IVPR Consumer Cyclical Personal Services
Inspire Veterinary Partners, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $16.6 million, roughly unchanged from fiscal 2023. In the quarter to September 2025, revenue grew 6.60%, EPS grew 51.7% and free cash flow grew 79.1%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow IVPR
| Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|
Piotroski F-Score |
4 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 |
Altman Z-Score |
(2.68) | 96.66 | — |
P/S ratio |
1.60 | 231.96 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(10.79) | (7.30) | (4.18) |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
Beneish M-Score |
(4.20) | (4.72) | — |
P/Operating CF |
(39.24) | (5,124.60) | (6,699.59) |
P/B ratio |
17.02 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 |
EV/Sales |
2.08 | 232.76 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(3.45) | (1,015.85) | (423.42) |
EV/FCF |
(2.96) | (923.14) | (391.91) |
Quick Ratio |
0.07 | 0.05 | 0.13 |
Current Ratio |
0.25 | 0.18 | 0.24 |
Net Debt/EBITDA |
(1.57) | (2.79) | (8.36) |
Debt/Assets |
42.04% | 61.88% | 86.23% |
Debt/Equity |
5.44 | (17.10) | (3.39) |
Asset Turnover |
0.79 | 0.79 | 0.00 |
Operating CF/Net income |
0.69 | 0.25 | 0.54 |
Capex/Depreciation |
(0.06) | (0.16) | (0.12) |
Interest Coverage |
(2.91) | (2.83) | (2.47) |
| (3,744.37%) | 508.60% | 0.00% | |
| (69.00%) | (71.77%) | 0.00% | |
ROIC |
(59.21%) | (35.83%) | (18.59%) |
Return on Tangible Assets |
(7,011.18%) | (876.13%) | (270.57%) |
Average Days of Receivables |
0.90 | 4.66 | 17.15 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
68.84% | 56.83% | 55.59% |
Intangible Assets out of Total Assets |
0.48 | 0.49 | 0.51 |
Share Based Compensation of Revenue |
0.14% | 0.00% | 0.00% |
Graham Net Nets |
(0.62) | (0.01) | (0.02) |
Graham Number |
0.00 | 82.60 | 0.00 |
Earnings Yield |
(68.68%) | (184.70%) | (41.29%) |
Free Cash Flow Yield |
(43.91%) | (0.11%) | (0.26%) |
Revenue per Share |
2.99 | 3.87 | 4,683.24 |
Operating CF per Share |
(1.80) | (0.89) | (1,265.86) |
Capex per Share |
(0.04) | (0.09) | (84.19) |
Free Cash Flow per Share |
(1.85) | (0.98) | (1,350.05) |
Cash per Share |
0.09 | 0.04 | 211.57 |
Shareholders Equity per Share |
0.28 | (0.18) | (2,445.48) |
Interest Debt per Share |
0.00 | 0.00 | 0.01 |
Book value per Share |
0.28 | (0.18) | (2,445.48) |
Free Cash Flow |
(10.24) | (4.20) | (2.84) |
Working Capital |
(6.18) | (6.23) | (5.51) |
Capital Expenditures |
(0.24) | (0.38) | (0.18) |
Net Current Asset Value |
(16.61) | (21.23) | (23.58) |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.62 | 0.30 | 0.20 |
Cash ROIC |
(96.86%) | (32.66%) | (22.30%) |
Accounts Receivable Turnover |
130.85 | 49.42 | 0.00 |
Accounts Payable Turnover |
5.13 | 6.21 | 0.00 |
Inventory Turnover |
24.44 | 22.75 | 0.00 |
Average Days of Payables |
54.33 | 89.20 | 51.02 |
Days of Inventory on Hand |
14.18 | 15.90 | 29.14 |
Average Receivables |
0.13 | 0.34 | — |
Average Payables |
2.59 | 2.11 | — |
Average Inventory |
0.54 | 0.58 | — |
Average Assets |
20.99 | 20.99 | — |
Average Common Equity |
0.39 | (2.96) | — |
Columns are period end dates